Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CHEK2 | O96017 | 2/20 | 0.41 |
| ▸ | PRSS12 | P56730 | 12/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15176810 | 0.92 | MAPT (0.47) | MAPTSMN1; SMN2POLBLMNACHEK2 | |
| SCHEMBL1913876 | 0.85 | MAPT (0.55) | MAPTSMN1; SMN2POLBLMNACHEK2 | |
| SCHEMBL20160570 | 0.82 | MMP2 (0.55) | MAPTSMN1; SMN2POLBLMNACHEK2 | |
| SCHEMBL13964434 | 0.81 | MMP2 (0.52) | MAPTSMN1; SMN2POLBLMNACHEK2 | |
| SCHEMBL8767560 | 0.74 | MAPT (0.51) | MAPTSMN1; SMN2POLBLMNAPRSS12 | |
| SCHEMBL13576605 | 0.72 | MMP2 (0.50) | MAPTSMN1; SMN2LMNAPRSS12TP53 | |
| SCHEMBL4894565 | 0.71 | MEN1 (0.56) | MAPTSMN1; SMN2POLBLMNAMEN1 | |
| SCHEMBL26597180 | 0.70 | PRSS12 (0.66) | MAPTSMN1; SMN2POLBLMNACHEK2 | |
| SCHEMBL6483677 | 0.70 | PRSS12 (0.66) | MAPTSMN1; SMN2POLBLMNACHEK2 | |
| SCHEMBL31748761 | 0.70 | PRSS12 (0.66) | MAPTSMN1; SMN2POLBLMNACHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050260126-A1 | Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein | BF RESEARCH INSTITUTE (JP) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050260126-A1 | Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein | PRNP, PRPH, PCNP | MAPT 7/4885SMN1; SMN2 214/4885POLB 2910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.